Novartis has issued a formal apology over misconduct relating to valsartan (Diovan) research in Japan, but that apology does not appear likely to satisfy the Japanese Health, Labor and Welfare Ministry, which plans to fully investigate the company’s role in the scandal. If necessary, ministry officials are prepared to raid the company’s offices in Japan.(...)
The expert panel found that Shirahashi was involved not only in the previously reported studies from the Jikei University School of Medicine and the Kyoto Prefectural University of Medicine, but was also involved in valsartan research conducted at Shiga University of Medical Science, Chiba University, and Nagoya University.(...)
The expert panel is not just looking at individual responsibility. According to an AFP news report, the panel has concluded that Novartis “should be held responsible for studies at various universities that used manipulated data on a popular blood pressure drug.”
Novartis: Hard to say i'm sorry / ソーリー a la japonesa (o...a los japoneses).